Table 1. Demographic characteristics and clinical outcomes of patients with COVID-19.
| Parameters | Mortality | |||
|---|---|---|---|---|
| No |
Yes |
Total |
p-value | |
| n (%) | n (%) | n (%) | ||
| Age (years) | <0.001 | |||
| – IQR | 21 | 17 | 21 | |
| – Median | 59 | 71 | 61 | |
| Age group (years) | ||||
| – 18–64 | 574 (64.6) | 42 (33.9) | 616 (60.8) | <0.001 |
| – 65–74 | 191 (21.5) | 37 (29.8) | 228 (22.5) | |
| – 75–84 | 98 (11) | 27 (21.8) | 125 (12.3) | |
| – >84 | 26 (2.9) | 18 (14.5) | 44 (4.3) | |
| Gender | ||||
| – Male | 516 (58) | 65 (52.4) | 581 (57.4) | 0.24 |
| – Female | 373 (42) | 59 (47.6) | 432 (42.6) | |
| Underlying diseases | 569 (64) | 103 (83) | 672 (66.3) | <0.001 |
| – COPD | 20 (2.3) | 4 (3.2) | 24 (2.4) | 0.52 |
| – Diabetes mellitus | 272 (30.6) | 51 (41.1) | 323 (31.9) | 0.02 |
| – Hypertension | 356 (40.0) | 72 (58.1) | 428 (42.3) | <0.001 |
| – Congestive heart failure | 36 (4.0) | 10 (8.1) | 46 (4.5) | 0.04 |
| – Chronic artery disease | 116 (13.0) | 27 (21.8) | 143 (14.1) | 0.01 |
| – Chronic renal failure | 38 (4.3) | 20 (16.1) | 58 (5.7) | <0.001 |
| – Malignancy | 21 (2.4) | 6 (4.8) | 27 (2.7) | 0.11 |
| – Cerebrovascular disease | 20 (2.3) | 8 (6.5) | 28 (2.8) | 0.01 |
| – Rheumatological disease | 18 (2) | 5 (4) | 23 (2.3) | 0.16 |
| – Neurological disorder | 16 (1.8) | 5 (4) | 21 (2) | 0.10 |
| Clinical outcomes | ||||
| – Invasive ventilation | 19 (2.1) | 116 (93.6) | 135 (13.3) | <0.001 |
| – ICU admission | 57 (6.4) | 118 (95.2) | 175 (17.3) | <0.001 |
| – Dialysis | 1 (0.1) | 10 (8.1) | 11 (1.1) | <0.001 |
| – Noninvasive ventilation | 57 (6.4) | 115 (92.7) | 172 (17) | <0.001 |
COPD: Chronic obstructive pulmonary disease; ICU: Intensive care unit; IQR: Interquartile range.